Green tea has long been touted for its role in helping to prevent conditions from Alzheimer’s disease to cancer. Now a recent study shows it carries an ingredient that helps reduce memory loss, brain insulin resistance, and one’s risk for obesity, too.
Research released by the Federation of American Societies for Experimental Biology shows that epigallocatechin-3-gallate (EGCG), a biologically-active ingredient prevalent in green tea, could alleviate high-fat, high-fructose-induced insulin resistance in the brain, as well as cognitive impairment.
While previous research has identified EGCG as a way to treat many diseases in humans, this latest study shows a positive impact on insulin resistance and cognitive defects triggered in the brain by an average Western diet.
“Green tea is the second most consumed beverage in the world after water, and is grown in at least 30 countries,” explains researcher Xuebo Liu, in a media release. “The ancient habit of drinking green tea may be a more acceptable alternative to medicine when it comes to combatting obesity, insulin resistance, and memory impairment.”